Study reports prevalence and associated factors of non-variceal upper gastrointestinal bleeding in cirrhotic patients, suggesting targeted interventions may help.
Non-variceal upper gastrointestinal bleeding accounted for nearly one-third (31.6%) of bleeding cases among cirrhosis patients with upper gastrointestinal bleeding. It was significantly associated with longer duration of cirrhosis, younger age, and the presence of comorbidities such as HIV. Targeted screening and preventive measures for high-risk patients may reduce the burden of NVUGIB.
No takes yet. Share an insight, caveat, or question.
Desalegn et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: